Sign in

CIK 0000109657

  • Non-accelerated filer
  • Smaller reporting company

GT Biopharma, Inc.

Sign in to watch
Ticker
GTBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
941620407
Phone
+1 800-304-9888
Business address
505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
Former names
GT Biopharma, Inc., OXIS INTERNATIONAL INC
  1. 4 Open-market sale Former Officer and Director sold 396,300 shares at an average $0.29 ($113,427)
  2. 4 Open-market sale CEO sold 4,234,320 shares at $0.00 ($4,234)
  3. 4 Open-market sale CFO sold 2,269,708 shares at $0.00 ($2,270)
  4. 4 Grant or award CEO acquired 7,000,000 shares (grant or award)
  5. 4 Grant or award CFO acquired 4,500,000 shares (grant or award)
  6. 4 Open-market sale CEO sold 176,980 shares at $0.00 ($177)
  7. 4 Open-market sale Director sold 800,000 shares at $0.00 ($800)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Executive Chairman acquired 5,129,660 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award CFO acquired 2,566,835 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale 10% owner sold 675,000 shares at $303,750.00 ($205,031,250,000)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 8 · 160 filings